You can watch RGLS and buy or sell other stocks, options, and ETFs commission-free!
Regulus Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development.
Joseph P. Hagan
San Diego, California
52 Week high
52 Week low